太阳成集团tyc122cc(中国)有限公司官网

Norroy’s First-in-Human Clinical Results for First-Generation Renal Cancer Radiopharmaceutical

目的 碳酸酐酶IX（CAIX）在透明细胞肾细胞癌（ccRCC）高度表达。本研究的目的是评估一种小分子的CAIX靶向PET示踪剂68Ga-NY104（NYM005），在ccRCC的肿瘤模型和确诊或疑似的ccRCC患者中的应用。   ...

MORE >>

Sunmao Medical first published the M1 Poster at iSRS 2023

The 25th International Symposium on Radiopharmaceutical Sciences was held in May 2023 in Hawaii. Abstract papers of Mortenon M1 were prese...

MORE >>

Norroy completed the A-round financing signing ceremony and continued cooperation with Xinghua Dingli.

Recently, Norroy Bioscience Co., Ltd. A-round of financing signing ceremony was held in Wuxi, Xinghua Dingli founder Mr. Wu Yuding and CEO of N...

MORE >>

Radioisotope workplace of Norroy bioscience officially put into use

Recently, the opening ceremony of the Radioisotope laboratory of Norroy bioscience Co., Ltd. was officially held in Wuxi. Mr. Wu Yuding, fo...

MORE >>